480 related articles for article (PubMed ID: 36055231)
21. Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer.
Li J; Li L; You P; Wei Y; Xu B
Semin Cancer Biol; 2023 Jun; 91():35-49. PubMed ID: 36868394
[TBL] [Abstract][Full Text] [Related]
22. Spatial multi-omics: novel tools to study the complexity of cardiovascular diseases.
Kiessling P; Kuppe C
Genome Med; 2024 Jan; 16(1):14. PubMed ID: 38238823
[TBL] [Abstract][Full Text] [Related]
23. Delivering precision oncology to patients with cancer.
Mateo J; Steuten L; Aftimos P; André F; Davies M; Garralda E; Geissler J; Husereau D; Martinez-Lopez I; Normanno N; Reis-Filho JS; Stefani S; Thomas DM; Westphalen CB; Voest E
Nat Med; 2022 Apr; 28(4):658-665. PubMed ID: 35440717
[TBL] [Abstract][Full Text] [Related]
24. Precision oncology based on omics data: The NCT Heidelberg experience.
Horak P; Klink B; Heining C; Gröschel S; Hutter B; Fröhlich M; Uhrig S; Hübschmann D; Schlesner M; Eils R; Richter D; Pfütze K; Geörg C; Meißburger B; Wolf S; Schulz A; Penzel R; Herpel E; Kirchner M; Lier A; Endris V; Singer S; Schirmacher P; Weichert W; Stenzinger A; Schlenk RF; Schröck E; Brors B; von Kalle C; Glimm H; Fröhling S
Int J Cancer; 2017 Sep; 141(5):877-886. PubMed ID: 28597939
[TBL] [Abstract][Full Text] [Related]
25. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
[TBL] [Abstract][Full Text] [Related]
26. Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response.
Valenti F; Falcone I; Ungania S; Desiderio F; Giacomini P; Bazzichetto C; Conciatori F; Gallo E; Cognetti F; Ciliberto G; Morrone A; Guerrisi A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917181
[TBL] [Abstract][Full Text] [Related]
27. Artificial intelligence-based multi-omics analysis fuels cancer precision medicine.
He X; Liu X; Zuo F; Shi H; Jing J
Semin Cancer Biol; 2023 Jan; 88():187-200. PubMed ID: 36596352
[TBL] [Abstract][Full Text] [Related]
28. A review of spatial profiling technologies for characterizing the tumor microenvironment in immuno-oncology.
Hu B; Sajid M; Lv R; Liu L; Sun C
Front Immunol; 2022; 13():996721. PubMed ID: 36389765
[TBL] [Abstract][Full Text] [Related]
29. Utility of Reverse-Phase Protein Array for Refining Precision Oncology.
Masuda M; Yamada T
Adv Exp Med Biol; 2019; 1188():239-249. PubMed ID: 31820392
[TBL] [Abstract][Full Text] [Related]
30. IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures.
Zeng D; Ye Z; Shen R; Yu G; Wu J; Xiong Y; Zhou R; Qiu W; Huang N; Sun L; Li X; Bin J; Liao Y; Shi M; Liao W
Front Immunol; 2021; 12():687975. PubMed ID: 34276676
[TBL] [Abstract][Full Text] [Related]
31. Breaks for Precision Medicine in Cancer: Development and Prospects of Spatiotemporal Transcriptomics.
Yan S; Guo Y; Lin L; Zhang W
Cancer Biother Radiopharm; 2024 Feb; 39(1):35-45. PubMed ID: 38181185
[TBL] [Abstract][Full Text] [Related]
32. Omics for the future in asthma.
Abdel-Aziz MI; Neerincx AH; Vijverberg SJ; Kraneveld AD; Maitland-van der Zee AH
Semin Immunopathol; 2020 Feb; 42(1):111-126. PubMed ID: 31942640
[TBL] [Abstract][Full Text] [Related]
33. The importance of precision medicine in modern molecular oncology.
Wang Y; Zheng D
Clin Genet; 2021 Sep; 100(3):248-257. PubMed ID: 33997970
[TBL] [Abstract][Full Text] [Related]
34. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
[TBL] [Abstract][Full Text] [Related]
35. Omics sciences and precision medicine in colon cancer.
Madeo G; Bonetti G; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Bernini A; Fulcheri E; Iaconelli A; Aquilanti B; Matera G; Stuppia L; Gatta V; Cecchin S; Marceddu G; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):55-67. PubMed ID: 37994749
[TBL] [Abstract][Full Text] [Related]
36. Multi-Omics Profiling for Health.
Babu M; Snyder M
Mol Cell Proteomics; 2023 Jun; 22(6):100561. PubMed ID: 37119971
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive molecular tumor profiling in radiation oncology: How it could be used for precision medicine.
Eke I; Makinde AY; Aryankalayil MJ; Ahmed MM; Coleman CN
Cancer Lett; 2016 Nov; 382(1):118-126. PubMed ID: 26828133
[TBL] [Abstract][Full Text] [Related]
38. [The promise of omics in the precision medicine era].
Tebani A; Bekri S
Rev Med Interne; 2022 Nov; 43(11):649-660. PubMed ID: 36041909
[TBL] [Abstract][Full Text] [Related]
39. Spatial dissection of the immune landscape of solid tumors to advance precision medicine.
Di Mauro F; Arbore G
Cancer Immunol Res; 2024 Apr; ():. PubMed ID: 38657223
[TBL] [Abstract][Full Text] [Related]
40. Precision diagnostics: integration of tissue pathology and genomics in cancer.
Sharma S; George P; Waddell N
Pathology; 2021 Dec; 53(7):809-817. PubMed ID: 34635323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
